BOSTON (AP) — The first coronavirus testing site at Boston’s Logan International Airport opened on Wednesday.
The site, located in Terminal E and operated by health and wellness company XpresSpa Group, will be for airport and airline employees at first but will start testing travelers, as well, in mid-November, the company said.… Read More
Diaceutics Launches World’s First Diagnostic Network for Precision Medicine to Solve Global Cancer Testing Issues
– Diaceutics today launches world’s first digital platform solution to broken testing ecosystem DXRX – The Diagnostic Network®
– Global pharma companies, labs and diagnostic companies are leveraging the platform with 38 laboratories and diagnostic companies onboarded and two pharma companies piloting the platform
– DXRX provides access to pipeline of global diagnostic testing data on one secure platform and enables industry-wide collaboration to accelerate biomarker test adoption and time to peak therapy prescription from years to months
– Early collaborations are now live on DXRX to address real-world cancer testing issues such as PD-L1 reimbursement in the US, and EQA Provision for NGS testing in EU and Asia
Diaceutics PLC, (AIM: DXRX), today announces the launch of DXRX – The Diagnostic Network® which has been designed to accelerate the end-to-end development and commercialization of precision medicine diagnostics by reducing time to peak biomarker test adoption for cancer testing from years to months. As a solution to today’s broken testing ecosystem, DXRX brings together stakeholders from across the industry to collaborate in a vibrant marketplace to solve real-world testing issues in a secure, standardized way for patients.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201028005588/en/
Sarah Colgan, Head of Global Marketing at Diaceutics (Photo: Business Wire)
DXRX integrates a pipeline of global diagnostic testing data into one secure platform providing access to transparent, real-time reporting on diagnostic utilization at a local level across multiple therapeutic areas.
Early collaborations between pharma, labs and diagnostic companies are live on the platform’s marketplace with 38 Laboratories and Diagnostic Companies onboarded from across EU, Asia and the US. These collaborations are designed to improve test standardization, reimbursement, regulatory support and External Quality Assessment (EQA). Collaborators today include Synlab, PathGroup (US), SRL Diagnostics (Asia), Fundación Jimenez Díaz, The Royal Marsden NHS Foundation Trust, Istituto Nazionale Tumori Regina Elena Roma and Diatech Pharmacogenetics (EU). Two global pharmaceutical clients are also piloting the technology.
The platform enables pharma clients to monitor and enhance test quality at local level to increase return on investment across multiple brands, and leverage a broad network of local partnership opportunities to implement best-in-class testing for their precision medicine portfolios. DXRX also enables clients to outsource the end-to-end diagnostic development and commercialization process from biomarker discovery to in-market test availability in order to reduce time to market for new therapies.
Furthermore, DXRX also provides users access to a global expert advisory panel of key opinion leaders from the areas of oncology, including lung cancer research and colorectal research; pathology, including tissue pathology and uropathology; molecular diagnostics; digital image analysis; telemedicine and informatics; external quality assessment (EQA); and FDA-expertise.
The end-to-end service offering provided by DXRX is enabled by a growing network of industry leading service providers in 51 countries. They cover precision medicine diagnostics to deliver implementation services such as test standardization, reimbursement, regulatory support and External Quality Assessment (EQA). Recent partnerships include Histocyte Laboratories, Targos Molecular Pathology, EMQN CIC, CPQA-ACP, NordiQC and UKNEQAS ICC & ISH.
In fact, the U.S. tallied a single-day record of more than 83,000 new Covid-19 cases on Friday, a new high-water mark as coronavirus has roared back across the country. Public health experts have warned that the fall and winter months will be an especially bleak period for Americans, as the coronavirus converges with the annual flu season.
But at a campaign rally in Michigan on Tuesday, Trump argued that the reason the U.S. has “so many cases” is “because we test more,” adding that “in many ways, I hate” testing.
“We test everybody, and because of that — now, if I tested half, if I said, ‘We are going to cut our testing down in half,’ they’d go crazy because the cases would go down in approximately half, right?” Trump told supporters.
Trump’s remarks come as he has sought to promote misleadingly positive assessments of the pandemic in the final days of the presidential race, returning to his false assertions that the U.S. is “rounding the turn” in its fight against the coronavirus.
Reports emerged over the weekend of another White House coronavirus outbreak among Vice President Mike Pence’s staff, and White House chief of staff Mark Meadows on Sunday seemingly acknowledged that the administration had given up on its efforts to contain the spread of Covid-19. “We’re not going to control the pandemic,” Meadows said.
Giroir disputed that message on Wednesday, saying that although the U.S. was at a “critical point” in its pandemic response, “we can control the virus” through mitigation measures including mask-wearing, hand-washing and avoiding crowded indoor spaces.
The North America food allergen testing market is expected to grow from US$ 201. 33 million in 2018 to US$ 403. 90 million by 2027; it is estimated to grow at a CAGR of 8. 1% from 2019 to 2027. Anaphylaxis and food allergy are among leading causes of public health risk in developed countries such as the US and Canada.
New York, Oct. 27, 2020 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “North America Food Allergen Testing Market Forecast to 2027 – COVID-19 Impact and Regional Analysis by Source, Technology, and Food Tested” – https://www.reportlinker.com/p05978897/?utm_source=GNW
Although the prevalence is higher in young children, recent studies indicate it is becoming more common in adolescents and young adults.
Moreover, there is growing evidence of the increasing prevalence of food allergies in rapidly developing countries.Food allergy incidence is rapidly rising in developed regions such as North America.
According to the Food Allergy Research and Education (FARE), ~32 million people in the US have some kind of food allergies. ~11% of people between the age group 18–26 million adults have food allergies in the US. ~40% of children in the country have multiple food allergies, i.e., they are allergic to more than one food type. In the US, 200,000 people require emergency medical care every year for allergic reactions caused due to food. The country also witnessed 377% increase in medical procedures to treat anaphylaxis or food allergies from 2007 to 2016. This further bolsters the growth of the food allergen testing market
In 2018, the milk segment led the North America food allergen testing market, based on source.Milk, as well as milk product, allergy is one of the most commonly found food allergies among children.
Cow milk is one of the usual causes of milk allergies; however, milk from sheep, buffalo, goats, and other mammals can also cause allergic reactions, which occur occurs soon after the consumption of milk.Signs and symptoms of milk allergy range from mild to severe, and they include vomiting, wheezing, hives, and digestive problems, varying from person to person.
Milk allergy can also cause anaphylaxis, a severe, life-threatening reaction.Avoiding milk and milk products is the prime solutions to avoid complications associated with milk allergies.
Apart from the symptoms mentioned above, immediate signs and symptoms might include itching or tingling feeling around the lips or mouth; swelling of the lips, tongue, or throat; and coughing or shortness of breath.
Presently, major countries in North America are under lockdown due to the COVID 19 pandemic.In the high-impact countries in the region, isolation and social distancing measures have been put in place.
The lesser production of goods and commodities is hampering the growth of the North America food allergen testing market as the demand for these solutions has declined over the past couple of months.The US has reported the highest number of confirmed cases of as the disease in this region.
The outbreak and measures taken to contain the infection spread are likely to impact the food &
The Trump administration’s testing czar, Brett Giroir, said Tuesday that the country’s increase in coronavirus cases is not just because of more testing but also a surge in the disease across the country.
His comments offer a stark contrast with those of President Trump.
“Testing may be identifying some more cases, I think that’s clearly true, but what we’re seeing is a real increase in the numbers,” Giroir, an assistant secretary of Health and Human Services, said at a Washington Post Live event.
“Compared to the post-Memorial Day surge, even though testing is up, this is a real increase in cases,” he added.
“We know that not only because the case numbers are up and we can calculate that, but we know that hospitalizations are going up.”
The rise in hospitalizations is widely used as an indicator to show that the spread of the virus really is worsening in the United States.
Trump however has continued to blame testing for the increase in cases.
“Cases up because we TEST, TEST, TEST,” he tweeted Monday. “A Fake News Media Conspiracy. Many young people who heal very fast. 99.9%. Corrupt Media conspiracy at all time high. On November 4th., topic will totally change. VOTE!”
Experts have widely said the increase is not just because of more testing.
There are about 43,000 people in the hospital with coronavirus, according to the Covid Tracking Project, up from about 30,000 at the beginning of the month.
The percentage of tests coming back positive is also rising, another indication that the rise in cases is not just because of increased testing.
Giroir said there are “several areas of the country where hospitals are becoming full and being stressed,” but noted that hospitalizations overall are still well below where they were during the July peak.
He offered a warning, though, that the situation can worsen and people need to wash their hands, wear masks, and maintain distance from others. The arrival of colder weather, as people move indoors, is expected to contribute to a spike.
“So you know we really have a mixed picture but we are tenuous now,” he said. “We really have to re-engage the public health measures that we know work or those hospitalizations can go up substantially.”
NEW YORK CITY — A new coronavirus screening programs aims to protect frontline MTA workers who literally keep the New York City region moving.
Roughly 2,000 MTA employees a week can receive receive free COVID-19 tests under a voluntary program announced Tuesday by MTA officials and Gov. Andrew Cuomo.
The program’s rapid tests will provide results in five minutes, officials said.
“Our brave frontline transit workers risked their lives to provide New Yorkers an essential service every single day during this pandemic, and we must support them just as they have supported us,” Cuomo said in a statement. “This new voluntary screening program leverages New York’s nation-leading COVID testing program to help keep our frontline workers safe during this unprecedented pandemic.”
The announcement came amid fears of a coronavirus “second wave” and MTA’s continued financial crisis tied to loss of ridership in the pandemic. Officials, in an effort to get straphangers back to buses and subways, have touted coronavirus safety measures and a recent study showing no link between public transit and COVID-19 outbreaks.
And a recent survey found one in four MTA workers said they have suffered a coronavirus infection.
Cuomo and other officials touted the testing program as a way to protect MTA workers. The effort’s first phase will have on-site testing in “field sites” — bus depots, subway and railroad train yards — that sit in coronavirus hot spot areas, a release states.
Additional testing will be offered at medical assessment centers, occupational health services facilities and Northwell Health-GoHealth urgent cares, officials said.
This article originally appeared on the New York City Patch
MAPLEWOOD, NJ — After this week, coronavirus testing will no longer be offered at the community pool in Maplewood. Instead, several other locations in Essex County will offer testing by appointment.
Testing at the community pool is offered by appointment and to walk-up patients. It will continue each day from 8 a.m. to 4 p.m. through Friday. Appointments can be made online.
Anyone hoping to get a test is reminded to bring to bring his or her insurance card and a form of identification. Uninsured people must bring a social security card to be tested for free.
Testing is offered regularly in Essex County. In the coming week, testing will also be offered at the following locations:
10/27/20 – Branch Brook Park (Cherry Blossom Center)
10/28/20 – Verona Community Pool
10/29/20 – Local 68 Training Center-West Caldwell
10/30/20 – Essex County Weequahic Park
11/2/20 – Archery Field-West Orange
Residents can sign up to get a test or to volunteer at a testing location on the county’s website.
As of Monday, Maplewood had reported 402 total cases of the coronavirus and 27 deaths caused by the COVID-19 virus. Maplewood reports 299 people have recovered from the coronavirus.
This article originally appeared on the Maplewood Patch
President Donald Trump has claimed over and over in the past week — at campaign rallies, on Twitter and in an interview with “60 Minutes” — that the US is only seeing so many coronavirus cases because the country is doing so much testing.
“Cases up because we TEST, TEST, TEST. A Fake News Media Conspiracy,” he wrote on Twitter on Monday morning.
Trump made similar claims during the summer spike in cases. They were flat wrong then, as we explained in a July fact check, and they are flat wrong now.
Facts First: The spike in US coronavirus cases is not being caused by an increase in testing. The number of confirmed new cases is increasing at a faster rate than the number of new tests. And the number of hospitalizations and deaths is also rising, which shows that, contrary to Trump’s repeated claims, the increase in the case numbers isn’t merely being caused by tests capturing mild cases. Taken together, the numbers tell a consistent story: the situation in the US is genuinely getting worse.
“To say that cases aren’t actually increasing is to deny reality,” Dr. Tom Frieden, who served as director of the Centers for Disease Control and Prevention under President Barack Obama, said in a Sunday email.
“Not only are cases and infections increasing, but hospitalizations — which follow case increases by several weeks — and deaths — which follow hospitalization increases by a week or two — are also increasing. What’s more, the proportion of tests that are positive has increased, and this correlates with increased actual spread of infection.” Frieden added: “The most reliable information is positivity, and this increased in all regions of the country.”
The national positivity rate as of Saturday was 6.1%, per Johns Hopkins University data, up from 4.6% a month prior.
If the increase in reported cases “were due to a very high level of testing, we would expect to see the percentage of tests that are positive be very low, certainly less than 3%. However that is not what we are seeing,” said Aubree Gordon, associate professor of epidemiology at the University of Michigan.
On Friday, the US set a new record for reported daily coronavirus cases: 83,757, according to Johns Hopkins data. Through Saturday, the seven-day average for daily new cases was 66,970 — the highest since late July.
The increase in daily cases is far outpacing the increase in daily testing. The COVID Tracking Project, an initiative that assembles and analyzes coronavirus data, tweeted on Saturday that “tests rose 3.8% from a week ago, while cases are up 20.6%.”
Trump has repeatedly suggested that the increase in confirmed cases is happening simply because tests are capturing cases
The US had more daily Covid-19 cases in the past week than ever before. And no, it’s not just due to more testing
Another day, another dreadful record broken in the Covid-19 pandemic.
This time, the seven-day average of daily new cases reached an all-time high of 68,767 on Sunday, according to data from Johns Hopkins University. The previous record of 67,293 was set July 22.
“Unfortunately, I think the statement about ‘new record’ is going to be repeated over and over again in the days and weeks to come,” said Dr. Ashish Jha, dean of the Brown University School of Public Health.
“I expect that those numbers will continue to climb. Hospitalizations are going to continue to climb.”
The abysmal week was marked by the two worst days of daily new cases reported since the pandemic began. More than 83,000 new cases were reported both Friday and Saturday, according to Johns Hopkins.
To be clear: This surge reflects an onslaught of new infections — not just increased testing, contrary to what skeptics claim.
“You know why we have cases? Because we test so much,” President Donald Trump claimed during a rally Saturday in North Carolina. “And in many ways, it’s good. And in many ways, it’s foolish.”
But the seven-day average of new Covid-19 cases has soared 23% in the past week, according to Johns Hopkins data. The seven-day average of new tests performed has risen only 2.87% over the past week, according to the Covid Tracking Project.
What happens when hospitals get overwhelmed
Some hospitals are starting to max out due to the new surge. And that’s bad news for everyone — not just those with coronavirus.
“We’ve seen what happened earlier in this pandemic, when hospitals become overwhelmed and patients end up not receiving care — not only patients with coronavirus, but also patients with heart attacks and strokes and were in car accidents,” emergency medicine physician Dr. Leana Wen said.
In Utah, for example, hospitals could be days away from using a patient’s age, health and other factors to decide who can stay in crowded intensive care units, and who won’t.
“That potentially could be occurring all over the country as our hospitals become overwhelmed,” Wen said. “And unlike last time, where it was only certain parts of the country that were experiencing this, now we have virus hotspots that are occurring everywhere.”
Video: ‘Great Influenza’ author outlines what herd immunity supporters won’t say (CNN)
As of Monday, at least 37 states had growing numbers of new Covid-19 cases this past week compared with the previous week, according to Johns Hopkins data. Thirteen states were holding roughly steady, and no state had Covid-19 decreases of at
OCEAN CITY, NJ — Here are the latest coronavirus updates around Ocean City and Cape May County.
The Cape May County Health Department reported the following in Ocean City as of Sunday morning — figures from Ocean City Patch’s last update Oct. 15 are in parenthesis.
resident active cases: 19 (11)
residents cleared off quarantine: 112 (98)
community deaths: one (one)
nonresident active cases: zero (one)
longterm-care active cases: zero (zero)
longterm-care cleared off quarantine: five (five)
longterm-care deaths: two (two)
New Jersey Coronavirus Updates: Don’t miss local and statewide announcements about coronavirus precautions. Sign up for Patch alerts and daily newsletters.
The CMCHD reported the following county-wide numbers as of Sunday morning:
community resident active cases: 122 (73 on Oct. 15)
community residents cleared off quarantine: 1,130 (1,089)
community deaths: 32 (30)
nonresident active cases: four (nine)
longterm-care active cases: two (two)
longterm-care cleared off quarantine: 188 (188)
longterm-care deaths: 62 (62)
See more data here.
Mobile coronavirus testing will come to Ocean City and Cape May County in the coming months. The county will develop mobile and walk-up testing options for people who have trouble accessing the county’s stationary testing sites. It may take some time though. Cape May County received a $552,513 grant through the New Jersey Department of Health, which the county will use to expand COVID-19 testing over the next six months. MORE.
An employee at the Motor Vehicle Commission Licensing Center in the Cardiff section of town tested positive for the coronavirus, the MVC announced Tuesday evening. The facility will reopen next Wednesday. MORE.
Despite a small bump in coronavirus inpatients, doctors told Ocean City Mayor Jay Gillian they are not “overly concerned.” But Gillian said everyone should continue to take precautions. MORE.
Here’s what else you should know:
Gov. Phil Murphy on Saturday extended New Jersey’s public health emergency amid the coronavirus crisis for the seventh time as the state reported its highest daily case number in five months. MORE.
Long lines have plagued New Jersey Motor Vehicle Commission Centers since its reopening in July. Starting Nov. 2, some of the MVC centers will no longer allow walk-ins, shifting to an appointment-only system. MORE.
Murphy has signed four coronavirus bills into law – two dealing with long-term care. MORE.
Click here to get Patch email notifications on this or other local news articles or get Patch breaking news alerts sent right to your phone with our app. Download here. Follow Ocean City Patch on Facebook. Have a news tip? Email firstname.lastname@example.org.
This article originally appeared on the Ocean City Patch